Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 13
2004 6
2005 11
2006 7
2007 9
2008 8
2009 10
2010 10
2011 9
2012 7
2013 7
2014 8
2015 6
2016 8
2017 14
2018 5
2019 9
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

148 results
Results by year
Filters applied: . Clear all
Page 1
Ovarian cancer.
Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Jayson GC, et al. Among authors: Kohn EC. Lancet. 2014 Oct 11;384(9951):1376-88. doi: 10.1016/S0140-6736(13)62146-7. Epub 2014 Apr 21. Lancet. 2014. PMID: 24767708 Review.
The MAPK pathway across different malignancies: a new perspective.
Burotto M, Chiou VL, Lee JM, Kohn EC. Burotto M, et al. Among authors: Kohn EC. Cancer. 2014 Nov 15;120(22):3446-56. doi: 10.1002/cncr.28864. Epub 2014 Jun 19. Cancer. 2014. PMID: 24948110 Free PMC article. Review.
Whence High-Grade Serous Ovarian Cancer.
Kohn EC, Ivy SP. Kohn EC, et al. Am Soc Clin Oncol Educ Book. 2017;37:443-448. doi: 10.1200/EDBK_174718. Am Soc Clin Oncol Educ Book. 2017. PMID: 28561656 Free article. Review.
PARP Inhibitors: The Cornerstone of DNA Repair-Targeted Therapies.
del Rivero J, Kohn EC. del Rivero J, et al. Among authors: Kohn EC. Oncology (Williston Park). 2017 Apr 15;31(4):265-73. Oncology (Williston Park). 2017. PMID: 28412778 Free article. Review.
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference.
Bast RC Jr, Matulonis UA, Sood AK, Ahmed AA, Amobi AE, Balkwill FR, Wielgos-Bonvallet M, Bowtell DDL, Brenton JD, Brugge JS, Coleman RL, Draetta GF, Doberstein K, Drapkin RI, Eckert MA, Edwards RP, Elias KM, Ennis D, Futreal A, Gershenson DM, Greenberg RA, Huntsman DG, Ji JXY, Kohn EC, Iavarone C, Lengyel ER, Levine DA, Lord CJ, Lu Z, Mills GB, Modugno F, Nelson BH, Odunsi K, Pilsworth JA, Rottapel RK, Powell DJ Jr, Shen L, Shih IM, Spriggs DR, Walton J, Zhang K, Zhang R, Zou L. Bast RC Jr, et al. Among authors: Kohn EC. Cancer. 2019 Jun 15;125(12):1963-1972. doi: 10.1002/cncr.32004. Epub 2019 Mar 5. Cancer. 2019. PMID: 30835824
New strategies in ovarian cancer treatment.
Lee JM, Minasian L, Kohn EC. Lee JM, et al. Among authors: Kohn EC. Cancer. 2019 Dec 15;125 Suppl 24:4623-4629. doi: 10.1002/cncr.32544. Cancer. 2019. PMID: 31967682 Review.
A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses.
Zimmer AS, Nichols E, Cimino-Mathews A, Peer C, Cao L, Lee MJ, Kohn EC, Annunziata CM, Lipkowitz S, Trepel JB, Sharma R, Mikkilineni L, Gatti-Mays M, Figg WD, Houston ND, Lee JM. Zimmer AS, et al. Among authors: Kohn EC. J Immunother Cancer. 2019 Jul 25;7(1):197. doi: 10.1186/s40425-019-0680-3. J Immunother Cancer. 2019. PMID: 31345267 Free PMC article.
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
Liu JF, Barry WT, Birrer M, Lee JM, Buckanovich RJ, Fleming GF, Rimel B, Buss MK, Nattam S, Hurteau J, Luo W, Quy P, Whalen C, Obermayer L, Lee H, Winer EP, Kohn EC, Ivy SP, Matulonis UA. Liu JF, et al. Among authors: Kohn EC. Lancet Oncol. 2014 Oct;15(11):1207-14. doi: 10.1016/S1470-2045(14)70391-2. Epub 2014 Sep 10. Lancet Oncol. 2014. PMID: 25218906 Free PMC article. Clinical Trial.
Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study.
Lee JM, Cimino-Mathews A, Peer CJ, Zimmer A, Lipkowitz S, Annunziata CM, Cao L, Harrell MI, Swisher EM, Houston N, Botesteanu DA, Taube JM, Thompson E, Ogurtsova A, Xu H, Nguyen J, Ho TW, Figg WD, Kohn EC. Lee JM, et al. Among authors: Kohn EC. J Clin Oncol. 2017 Jul 1;35(19):2193-2202. doi: 10.1200/JCO.2016.72.1340. Epub 2017 May 4. J Clin Oncol. 2017. PMID: 28471727 Free PMC article. Clinical Trial.
148 results
Jump to page
Feedback